Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07369765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Biruni University
- Registry
-
NCT07369765
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Türkiye
- Registry status
- Recruiting
Technical summary
Registry record NCT07369765. Randomized; no masking; primary purpose treatment. Start 2025-08-28 (actual); primary completion 2026-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial
- Acronym
- DCB-CTO
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Drug-Eluting Stent Group
- Intervention (Device)
- Drug Coated Balloon Group
- Lead sponsor
- Biruni University
Record details
- Record id
cardio:ct-nct07369765- Content hash
0da441d3fda3839c216b11a97c6dd8d9a234d63c2bb3c0ea058ed9dd1424cfff